Research
Energy balance
Tirzepatide has a half-life of five days, allowing for once-weekly administration.
Practitioners can schedule tirzepatide administration once a week due to its five-day half-life.
StrongSupportsmedium confidence
A tirzepatida tem uma meia-vida de cinco dias, permitindo a administração uma vez por semana.
Why this rating
The claim is based on a clear pharmacokinetic detail provided in the abstract.
Source
Evidências cientificas sobre o uso de tirzepatida como tratamento da obesidade
Bernardo Carneiro de Sousa Guimarães et al. · Brazilian Journal of Health Review · 2022
DOI 10.34119/bjhrv5n4-137
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →